📊 Score Breakdown
Offering Ability
100
Cash Runway
95
Float Risk
70
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌩️
Severe
Multiple high-probability dilution events detected
63%
💰 Capital Raise
93%
• Critical: only 1.0 months cash remaining
• Active shelf registration ($300M, 241% of market cap)
📉 Score Deterioration
55%
• Score rose 56 points recently (worsening)
• Score already CRITICAL (83/100) — events likely imminent
💹 Market Data
Market Cap$124.60M
Shares Outstanding26.01M
Float7.99M
Cash$138.6K
Debt$346.1K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 28.8% shares (2025Q4 vs prior)
23 institutional holders · 2.36M shares
#1
HighPoint Advisor Group LLC
1.14M shares
#2
BANK OF AMERICA CORP /DE/
450.8K shares
#3
VANGUARD GROUP INC
181.0K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest274.8K
Days to Cover3.9
% of Float3.4%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2024
424B5
ATM
Apr 16, 2026
EFFECT
EFFECT
Apr 16, 2026
3
FORM3
Apr 13, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NTHI
📊 NTHI FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NTHI Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.